Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
Condition: Ototoxic Hearing Loss Intervention: Drug: N-Acetyl Cysteine Sponsors: Sunnybrook Health Sciences Centre; Toronto Sunnybrook Regional Cancer Centre; London Regional Cancer Program, Canada Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials